home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

30.87 +1.38 (+4.68%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? ↗

January 19, 2025

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...

Via Benzinga

Is Moderna Stock a Buy? ↗

January 19, 2025

Via The Motley Fool

These Were the 5 Worst-Performing Stocks in the S&P 500 in 2024 ↗

January 18, 2025

Via The Motley Fool

Topics Stocks

Moderna Announces Updates on Pandemic Influenza Program

January 17, 2025

Via ACCESS Newswire

Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review ↗

January 17, 2025

Many stocks flashed buy signals as the major indexes rose to or above key levels.

Via Investor's Business Daily

Topics Economy

Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? ↗

January 16, 2025

Via The Motley Fool

Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks ↗

January 17, 2025

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns.

Via Investor's Business Daily

Topics Government

Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing ↗

January 16, 2025

The CDC issued a health advisory Thursday recommending that hospitalized patients who have tested positive for influenza be tested for the bird flu virus within 24 hours.

Via Benzinga

Is Moderna a Bad-News Buy for 2025? ↗

January 16, 2025

Via The Motley Fool

Down 79%, Is Moderna Stock a Bad-News Buy on the Dip? ↗

January 16, 2025

Via The Motley Fool

Moderna Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) ↗

January 15, 2025

Via Benzinga

Is Moderna Stock a No-Brainer Buy on the Sell-Off? ↗

January 15, 2025

Via The Motley Fool

Moderna Stock Takes A 20% Hit ↗

January 13, 2025

Moderna stock is now down close to 30% versus its YTD high.

Via Talk Markets

Topics Stocks / Equities

Why Moderna Stock Just Crashed 21% ↗

January 13, 2025

Via The Motley Fool

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

January 13, 2025

Via ACCESSWIRE

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell? ↗

January 14, 2025

Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.

Via Investor's Business Daily

Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday? ↗

January 13, 2025

Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal Reserve interest rate policy.

Via Benzinga

Topics Economy

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge ↗

January 13, 2025

Via Benzinga

Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge ↗

January 13, 2025

Via Benzinga

Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance Cut: Retail’s Shaken ↗

January 13, 2025

The revised projection largely reflects declining COVID-19 vaccine demand, as fewer people seek boosters amid the ongoing shift to an endemic phase.

Via Stocktwits

Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance ↗

January 13, 2025

The company also had a setback for its CMV vaccine.

Via Investor's Business Daily

Moderna Expects Lower Annual Sales, Expands Cost-Cutting Initiatives ↗

January 13, 2025

Moderna targets ten product approvals by 2027 while cutting R&D costs by $1.1 billion. FY2024 revenue reached $3 billion-$3.1 billion, with $9.5B in cash reserves.

Via Benzinga

MarketBeat Week in Review – 01/06 - 01/10

January 11, 2025

Stocks continued to slide after a hot jobs report sent bond yields higher, lowered expectations for future rate cuts, and keeps inflation and earnings in focus

Via MarketBeat

Topics Bonds Economy Government

10 Worst Performing Large-Caps Last 12 Months ↗

January 09, 2025

Here’s this week’s top ten worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Via Investor's Business Daily

Topics Artificial Intelligence Government

"Motley Fool Money" 2025 Stock Market Preview ↗

January 08, 2025

New year, new market? Motley Fool analysts preview what's in store for investors in 2025, the companies they're excited to watch and the businesses they're worried about.

Via The Motley Fool

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies ↗

January 08, 2025

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Via Benzinga

Topics ETFs

Moderna Shares Spike on H5N1 News—What’s Next for Investors?

January 08, 2025

MRNA stock surged over 12% on growing bird flu concerns; that rally may not last, but analysts believe the company's pipeline makes the stock a Buy in 2025

Via MarketBeat

Prediction: These Could Be the Best-Performing Value Stocks Through 2030 ↗

January 08, 2025

Via The Motley Fool

Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

January 07, 2025

The U.S. stock market experienced a downturn on Tuesday, with the Nasdaq Composite falling by 1.9% and the S&P 500 dropping by 1.1%..

Via Benzinga

Topics Stocks

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com